These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29759565)

  • 21. Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro.
    Xin W; Zhang L; Sun F; Jiang N; Fan H; Wang T; Li Z; He J; Fu F
    Phytomedicine; 2011 Feb; 18(4):272-7. PubMed ID: 20850956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular mechanisms of anti-inflammatory actions of glucocorticoids and their synergy with beta2-agonists].
    Obojski A; Kraus-Filarska M
    Pol Arch Med Wewn; 2004 Jun; 111(6):743-7. PubMed ID: 15508799
    [No Abstract]   [Full Text] [Related]  

  • 23. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid-resistant asthma and novel anti-inflammatory drugs.
    Keenan CR; Salem S; Fietz ER; Gualano RC; Stewart AG
    Drug Discov Today; 2012 Sep; 17(17-18):1031-8. PubMed ID: 22659097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid regulation of cancer development and progression.
    Khadka S; Druffner SR; Duncan BC; Busada JT
    Front Endocrinol (Lausanne); 2023; 14():1161768. PubMed ID: 37143725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-inflammatory and immunosuppressive properties of corticosteroids].
    Guilpain P; Le Jeunne C
    Presse Med; 2012 Apr; 41(4):378-83. PubMed ID: 22361029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoids and sepsis.
    Allary J; Annane D
    Minerva Anestesiol; 2005 Dec; 71(12):759-68. PubMed ID: 16288183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging from their burrow: Hedgehog pathway inhibitors for cancer.
    Gan GN; Jimeno A
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1153-66. PubMed ID: 27459882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Steroid therapy in oncology].
    Tsurumi H
    Nihon Rinsho; 2008 Jan; 66(1):143-7. PubMed ID: 18193553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases.
    Herr I; Pfitzenmaier J
    Lancet Oncol; 2006 May; 7(5):425-30. PubMed ID: 16648047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
    Newton R; Leigh R; Giembycz MA
    Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of glucocorticoid in anti-inflammatory effects of Ro5-4864 in mouse pleurisy induced by carrageenan.
    Farges RC; da Silva MB; Fröde TS
    Life Sci; 2006 Mar; 78(16):1814-22. PubMed ID: 16271371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation.
    Coimbra M; Banciu M; Fens MH; de Smet L; Cabaj M; Metselaar JM; Storm G; Schiffelers RM
    J Control Release; 2010 Dec; 148(3):303-10. PubMed ID: 20869410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Non-Conventional Effects of Glucocorticoids in Cancer.
    Azher S; Azami O; Amato C; McCullough M; Celentano A; Cirillo N
    J Cell Physiol; 2016 Nov; 231(11):2368-73. PubMed ID: 27115293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin may participate in the antiinflammatory actions of glucocorticoids.
    Karalis K; Mastorakos G; Sano H; Wilder RL; Chrousos GP
    Endocrinology; 1995 Sep; 136(9):4133-8. PubMed ID: 7544277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prescription and surveillance of steroidal and non-steroidal anti-inflammatory drugs].
    Berenbaum F
    Rev Prat; 2004 Apr; 54(7):781-9. PubMed ID: 15253298
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
    Drebert Z; Bracke M; Beck IM
    J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
    Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
    Orqueda AJ; Dansey MV; Español A; Veleiro AS; Bal de Kier Joffé E; Sales ME; Burton G; Pecci A
    Biochem Pharmacol; 2014 Jun; 89(4):526-35. PubMed ID: 24735610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.